Liraglutide relieves cardiac dilated function than DPP‐4 inhibitors

INTRODUCTION: Diabetes mellitus is a progressive disease with cardiovascular complications. This study evaluated the effects of liraglutide, a glucagon‐like peptide‐1 analogue and the dipeptidyl peptidase 4 inhibitors sitagliptin and linagliptin on cardiac function in type 2 diabetes patients with r...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiramatsu, Takeyuki, Asano, Yuko, Mabuchi, Masatsuna, Imai, Kentaro, Iguchi, Daiki, Furuta, Shinji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175244/
https://www.ncbi.nlm.nih.gov/pubmed/30054920
http://dx.doi.org/10.1111/eci.13007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175244/
https://www.ncbi.nlm.nih.gov/pubmed/30054920
http://dx.doi.org/10.1111/eci.13007

Ejemplares similares